about
DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinomaEpigenetics in non-small cell lung cancer: from basics to therapeuticsDNA methylation biomarkers: cancer and beyondTumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectivesArtificial light at night: melatonin as a mediator between the environment and epigenomeOxidative stress, telomere shortening, and DNA methylation in relation to low-to-moderate occupational exposure to welding fumesEarly lung cancer diagnosis by biosensors.Social determinants and the classification of disease: descriptive epidemiology of selected socially mediated disease constellationsIntegrating omics technologies to study pulmonary physiology and pathology at the systems level.Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers.Uncovering Driver DNA Methylation Events in Nonsmoking Early Stage Lung Adenocarcinoma.Research status and funding trends of lung cancer biomarkers.Smoking-associated DNA methylation markers predict lung cancer incidence.Glycemic memories and the epigenetic component of diabetic nephropathy.The roles of AXIN2 in tumorigenesis and epigenetic regulation.Epigenetics in lung cancer diagnosis and therapy.Current and future molecular diagnostics in non-small-cell lung cancer.The potential of DNA modifications as biomarkers and therapeutic targets in oncology.Epigenetic Regulation of the Epithelial to Mesenchymal Transition in Lung Cancer.A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells.Pathway deviation-based biomarker and multi-effect target identification in asbestos-related squamous cell carcinoma of the lung.Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer.IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer.F2RL3 methylation, lung cancer incidence and mortality.Translational medicine individualizes healthcare discovery, development and delivery. Foreword.Overexpression of HP1γ is associated with poor prognosis in non-small cell lung cancer cell through promoting cell survival.Altered miR-223 Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer.Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer.Sputum-based DNA methylation biomarkers to guide lung cancer screening decisions.3D-cultivation of NSCLC cell lines induce gene expression alterations of key cancer-associated pathways and mimic in-vivo conditions.Serum and blood based biomarkers for lung cancer screening: a systematic review.Potential prognostic biomarkers identified by DNA methylation profiling analysis for patients with lung adenocarcinoma.Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
P2860
Q24606042-5F641612-6BB6-460D-A2A9-6530E5EBC41CQ26749113-A543D3E9-114C-48C3-A163-B989F48F1114Q26996421-5CB564CF-D55B-4582-BD8B-0F1C77B8D199Q27014117-4D5B7C8E-638E-435D-8D02-66F0673D640EQ28085136-1E5C79A3-2878-4606-9D1A-C432185DB1C4Q28387165-09B82D2C-E9AF-4C27-8B73-24454EDC4C84Q30449799-40AB2B38-D09B-4224-B520-6CECB1370FC1Q34455988-679B6BB2-0C2F-4847-B347-22210D242F0EQ35413415-46359A38-7368-456B-A1FB-5CDC93DD536BQ37162642-065A2A90-0794-43DE-A77A-7EDEBF4A2DCBQ37219171-1C9E5CA2-39B9-4972-943B-6C5BB63BC88CQ37274578-4A7A4275-1D29-4EA8-8449-E2A9810AA3A9Q37440262-A640920A-61BD-46CB-B106-D19A5BC8D652Q38103744-150EE68A-A1CA-4245-A054-B69E9D164952Q38287688-544F9D7E-0D01-4075-9041-D2E643F8FEA8Q38457939-E403CF48-F41F-4063-8896-18FC95D433DFQ38543780-809D7683-898F-4735-95F8-93F46430697AQ38591064-2A39EA15-E575-4A87-A4B4-3A806BEE31BAQ38696030-F05DD4D7-7038-4236-8A23-66D3CA9BDE4DQ38811674-76224576-07D2-4883-8AE9-663D14F2AFF5Q38836957-451B353E-BFF5-4610-9260-61DD092C0BDAQ38871447-54D94100-CD47-4C4E-B351-3A6D9E8F00F6Q41317361-88F80CFD-98BC-4A38-BF00-88E1D497B728Q42164215-2A5DD6D4-AFB9-4853-ACC6-08C89DFDC2DCQ44021766-8CEBD9DB-70EB-4116-A14C-9846A7F67350Q45043969-2A70605B-CD40-479A-8C47-4F3505450512Q46250388-8D9B8EF0-A28D-4EF2-AAFE-C9D722DB82A6Q47096258-192497C5-B9BF-4796-8FD8-E2025A6936D9Q47129993-E92B40B9-EDAA-419A-9FBF-B7710F72DCC7Q47141129-EF5361BC-C22C-48F3-ACA2-433650AFC465Q49178345-7BD67383-F46B-46FB-A47B-07BB3BB53FE3Q50033192-BC298427-040C-4599-993C-AB19E637556CQ50223333-CFB91C67-63CE-4860-BAF2-F7C6C147EDDDQ56892179-FFBED8E5-43DC-4E66-9866-56B078D52365
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lung cancer epigenetics: emerging biomarkers
@ast
Lung cancer epigenetics: emerging biomarkers
@en
Lung cancer epigenetics: emerging biomarkers
@nl
type
label
Lung cancer epigenetics: emerging biomarkers
@ast
Lung cancer epigenetics: emerging biomarkers
@en
Lung cancer epigenetics: emerging biomarkers
@nl
prefLabel
Lung cancer epigenetics: emerging biomarkers
@ast
Lung cancer epigenetics: emerging biomarkers
@en
Lung cancer epigenetics: emerging biomarkers
@nl
P2093
P2860
P3181
P356
P1476
Lung cancer epigenetics: emerging biomarkers
@en
P2093
Evi S Lianidou
Ioanna Balgkouranidou
Triantafillos Liloglou
P2860
P3181
P356
10.2217/BMM.12.111
P407
P577
2013-02-01T00:00:00Z